Globus Medical (NYSE: GMED)
Globus Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Globus Medical Company Info
This medical device company designs and sells products that alleviate spine disorders.
News & Analysis
Globus Medical (GMED) Q2 Revenue Up 18%
Globus Medical: Q4 Revenue Tops Forecast
Globus Medical's robust earnings for Q4 2024 were driven by strategic acquisitions and sustained innovation.
Globus Medical's EPS Tops Forecast in Q3
The medical device maker reported big growth in revenue and earnings, driven by strong product sales and a recent major acquisition.
Investing in Life Sciences Stocks
Globus Medical: NuVasive Fuels Q2 Revenue Surge
Globus Medical announced robust revenue growth for Q2 2024, driven by the NuVasive acquisition, but faced significant declines in GAAP net income.
Could Globus Medical Be the Best Healthcare Stock?
Globus Medical makes surgery faster and safer.
Is Globus Medical a Great Stock to Buy Right Now?
International sales were down in the most recent quarter.
Is Globus Medical's Robotic Surgery Business a Winner?
It's still early, but things look promising.
Valuation
Earnings Transcripts
Globus Medical (GMED) Q4 2024 Earnings Call Transcript
GMED earnings call for the period ending December 31, 2024.
Globus Medical (GMED) Q3 2024 Earnings Call Transcript
GMED earnings call for the period ending September 30, 2024.
Globus Medical (GMED) Q2 2024 Earnings Call Transcript
GMED earnings call for the period ending June 30, 2024.
Globus Medical (GMED) Q1 2024 Earnings Call Transcript
GMED earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.